Metabolic impact on serum levels of complement component 3 in Japanese patients

Journal of Clinical Laboratory Analysis

Volumn 24, Issue 2, 2010, Pages 113-118

  Ohsawa, Isao ^a   Inoshita, Hiroyuki ^a   Ishii, Masaya ^a   Kusaba, Gaku ^a   Sato, Nobuyuki ^a   Mano, Satoshi ^a   Onda, Kisara ^a   Gohda, Tomohito ^a   Horikoshi, Satoshi ^a   Ohi, Hiroyuki ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acylation stimmulating protein (ASP); C3; C3a desArg; Insulin resistance; Metabolic syndrome

Indexed keywords

ALBUMIN; CHOLESTEROL; COMPLEMENT COMPONENT C3; HEMOGLOBIN; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BODY MASS; COMPLEMENT HEMOLYSIS TEST; FEMALE; HEMATOCRIT; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; WAIST CIRCUMFERENCE;

BIOLOGICAL MARKERS; COMORBIDITY; COMPLEMENT C3; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; HYPERURICEMIA; INSULIN RESISTANCE; JAPAN; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 77951543907     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20372     Document Type: Article

References (25)

1. Hafez M, Aref GH, Mehareb SW, et al. Antibody production and complement system in protein energy malnutrition. J Trop Med Hyg 1977;80:36-39.
2. Haller L, Zubler RH, Lambert PH. Plasma levels of complement components and complement haemolytic activity in protein-energy malnutrition. Clin Exp Immunol 1978;34:248-252.
3. Keusch GT, Torun B, Johnson RB, Urrtua JJ. Impairment of haemolytic complement activation by both classical and alternative pathways in serum from patients with kwashiorkor. Clin Lab Observ 1984;105:434-436.
4. Colten HR, Ooi YM, Edelson PJ. Synthesis and secretion of complement proteins by macrophages. Ann N Y Acad Sci 1979;332:482-490.
5. Botto M, Lissandrini D, Sorio C, Walport MJ. Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes. J Immunol 1992;149:1348-1355.
6. Brooimans RA, Stegmann AP, van Dorp WT, et al. Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest 1991;88:379-384.
7. Ohsawa I, Ohi H, Endo M, Fujita T, Kanmatsuse K, Nonaka M. Novel estimation of histologic activity in human glomerulonephritis by detection of complement component C3 messenger RNA. Clin Exp Nephrol 1998;2:50-57.
8. Naughton MA, Botto M, Carter MJ, Alexander GJ, Goldman JM, Walport MJ. Extrahepatic secreted complement C3 contributes to circulating C3 levels in humans. J Immunol 1996;156:3051-3056.
9. Choy LN, Rosen BS, Spiegelman BM. Adipsin and endogeneous pathway of complement from adipose cells. J Biol Chem 1992;267:12736-12742.
10. Pomeroy C, Mitchel J, Eckert E, Raymond N, Crosby R, Dalmasso AP. Effect of body weight and caloric restriction on serum complement proteins, including factor D/adipsin: Studies in anorexia nervosa and obesity. Clin Exp Immunol 1997;108:507-515.
11. Weyer C, Tataranni PA, Pratley RE. Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration. Diabetes Care 2000;23:779-785.
12. Halkes CJM, van Dijk H, de Jaegere PPT, et al. Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease. Effects of expanded dose of simvastatin. Arterioscler Thromb Vasc Biol 2001;21:1526-1530.
13. Yu H, Yang Y, Zhang M, et al. Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects. Nutr Metab (Lond) 2006;10:3-13.
14. Razzouk L, Muntner P. Ethnic, gender, and age-related differences in patients with the metabolic syndrome. Curr Hypertens Rep 2009;11:127-132.
15. Ogden CL, Yanovski SZ, Caroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology 2007;132:2087-2102.
16. Japanese Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Definition and the diagnostic standard for metabolic syndrome. Nippon Naika Gakkai Zasshi 2005;94:794-809 (in Japanese).
17. Matsuzawa Y. Metabolic syndrome-definition and diagnostic criteria in Japan. J Atheroscler Thromb 2005;12:301.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Insulin resistance was assessed using the Homeostasis Model Assessment (HOMA): Fasting serum insulin (μU/mL) x fasting plasma glucose (mg/dL). Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985;28:412-419.
19. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982-992.
20. Van Harmelen V, Reynisdottir S, Cianflone K, et al. Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin. J Biol Chem 1999;274:18243-18251.
21. Yasruel Z, Cianflone K, Sniderman AD, Rosenbloom M, Walsh M, Rodriguez MA. Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids 1991;26:495-499.
22. Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 2008;14:222-231.
23. Muscari A, Bastagli L, Poggiopollini G, et al. Different associations of C-reactive protein, fibrinogen, and C3 with traditional risk factors in middle-aged men. Int J Cardiol 2002;83:63-71.
24. Onat A, Uzunlar B, Hergenζ G, et al. Cross-sectional study of complement C3 as a coronary risk factor among men and women. Clin Sci 2005;108:129-135.
25. Muller-Eberhard HJ. Molecular organization and function of the complement system. Annu Rev Biochem 1988;57:321-347.